HPV DNA as a Biomarker in Oropharyngeal Cancer: A Step in the Right Direction.

Colevas, A Dimitrios · Clin Cancer Res · 2022

editorial · Level V

Where this comes from

Abstract

Lack of prospectively planned follow-up and minimal characterization of the patient population studied complicate interpretation of circulating human papillomavirus (HPV) DNA as a prognostic biomarker for patients with HPV-associated oropharyngeal carcinoma treated with curative intent. See related article by Berger et al., p. 4292.

Medical subject headings